GlycoMimetics Inc (GLYC)

0.242 +0.03 (+11.78%) USD  |  NASDAQ  |  Dec 24, 16:00
More

GlycoMimetics Cash and Short Term Investments (Quarterly): 14.39M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 930.44M
Arbutus Biopharma Corp 127.79M
Revance Therapeutics Inc 184.08M
FibroGen Inc 131.00M
Cidara Therapeutics Inc 127.39M